Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-044724
Filing Date
2024-02-26
Accepted
2024-02-23 17:32:06
Documents
20
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d798749d10ka.htm   iXBRL 10-K/A 39088
2 EX-23.1 d798749dex231.htm EX-23.1 2362
3 EX-31.1 d798749dex311.htm EX-31.1 3405
4 EX-31.2 d798749dex312.htm EX-31.2 3226
  Complete submission text file 0001193125-24-044724.txt   255119

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nerv-20231231.xsd EX-101.SCH 4976
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20231231_cal.xml EX-101.CAL 978
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20231231_def.xml EX-101.DEF 3278
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20231231_lab.xml EX-101.LAB 23045
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20231231_pre.xml EX-101.PRE 18436
22 EXTRACTED XBRL INSTANCE DOCUMENT d798749d10ka_htm.xml XML 8406
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36517 | Film No.: 24672792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)